![T83 T83](https://data.pdbj.org/pdbjplus/data/cc/svg/T83.svg) | T83 | Name: | 7-hydroxy-6-methoxy-2H-1-benzopyran-2-one | Formula: | C10 H8 O4 | SMILES: | COc1cc2C=CC(=O)Oc2cc1O | InChi: | InChI=1S/C10H8O4/c1-13-9-4-6-2-3-10(12)14-8(6)5-7(9)11/h2-5,11H,1H3 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 7-hydroxy-6-methoxy-2H-1-benzopyran-2-one |
|
![T8Q T8Q](https://data.pdbj.org/pdbjplus/data/cc/svg/T8Q.svg) | T8Q | Name: | N-{3-[1-(tert-butoxycarbonyl)piperidin-4-yl]propyl}adenosine | Formula: | C23 H36 N6 O6 | SMILES: | CC(C)(C)OC(=O)N1CCC(CC1)CCCNc1ncnc2c1ncn2C1OC(CO)C(O)C1O | InChi: | InChI=1S/C23H36N6O6/c1-23(2,3)35-22(33)28-9-6-14(7-10-28)5-4-8-24-19-16-20(26-12-25-19)29(13-27-16)21-18(32)17(31)15(11-30)34-21/h12-15,17-18,21,30-32H,4-11H2,1-3H3,(H,24,25,26)/t15-,17-,18-,21-/m1/s1 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-{3-[1-(tert-butoxycarbonyl)piperidin-4-yl]propyl}adenosine |
|
![T96 T96](https://data.pdbj.org/pdbjplus/data/cc/svg/T96.svg) | T96 | Name: | N-[(4-aminophenyl)methyl]adenosine | Formula: | C17 H20 N6 O4 | SMILES: | Nc1ccc(cc1)CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O | InChi: | InChI=1S/C17H20N6O4/c18-10-3-1-9(2-4-10)5-19-15-12-16(21-7-20-15)23(8-22-12)17-14(26)13(25)11(6-24)27-17/h1-4,7-8,11,13-14,17,24-26H,5-6,18H2,(H,19,20,21)/t11-,13-,14-,17-/m1/s1 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-[(4-aminophenyl)methyl]adenosine |
|
![XKR XKR](https://data.pdbj.org/pdbjplus/data/cc/svg/XKR.svg) | XKR | Name: | N-{(1S)-2-amino-1-[4,5-bis(hydroxymethyl)-1,3-thiazol-2-yl]ethyl}-5-(4-chloro-3,5-difluorophenyl)-1H-pyrrole-2-carboxamide | Formula: | C18 H17 Cl F2 N4 O3 S | SMILES: | O=C(NC(CN)c1nc(CO)c(CO)s1)c1ccc([NH]1)c1cc(F)c(Cl)c(F)c1 | InChi: | InChI=1S/C18H17ClF2N4O3S/c19-16-9(20)3-8(4-10(16)21)11-1-2-12(23-11)17(28)24-13(5-22)18-25-14(6-26)15(7-27)29-18/h1-4,13,23,26-27H,5-7,22H2,(H,24,28)/t13-/m0/s1 | Synonyms: | NBD-14208 | Definition date: | 2022-11-28 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-{(1S)-2-amino-1-[4,5-bis(hydroxymethyl)-1,3-thiazol-2-yl]ethyl}-5-(4-chloro-3,5-difluorophenyl)-1H-pyrrole-2-carboxamide |
|
![XKW XKW](https://data.pdbj.org/pdbjplus/data/cc/svg/XKW.svg) | XKW | Name: | (5M)-N-{(1S)-2-amino-1-[5-(hydroxymethyl)-1,3-thiazol-2-yl]ethyl}-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrrole-2-carboxamide | Formula: | C17 H16 F3 N5 O2 S | SMILES: | O=C(NC(CN)c1ncc(CO)s1)c1ccc([NH]1)c1ccc(cn1)C(F)(F)F | InChi: | InChI=1S/C17H16F3N5O2S/c18-17(19,20)9-1-2-11(22-6-9)12-3-4-13(24-12)15(27)25-14(5-21)16-23-7-10(8-26)28-16/h1-4,6-7,14,24,26H,5,8,21H2,(H,25,27)/t14-/m0/s1 | Definition date: | 2022-11-28 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (5M)-N-{(1S)-2-amino-1-[5-(hydroxymethyl)-1,3-thiazol-2-yl]ethyl}-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrrole-2-carboxamide |
|
![T9I T9I](https://data.pdbj.org/pdbjplus/data/cc/svg/T9I.svg) | T9I | Name: | N-[(1R)-2,3-dihydro-1H-inden-1-yl]adenosine | Formula: | C19 H21 N5 O4 | SMILES: | OCC1OC(n2cnc3c(NC4CCc5ccccc54)ncnc32)C(O)C1O | InChi: | InChI=1S/C19H21N5O4/c25-7-13-15(26)16(27)19(28-13)24-9-22-14-17(20-8-21-18(14)24)23-12-6-5-10-3-1-2-4-11(10)12/h1-4,8-9,12-13,15-16,19,25-27H,5-7H2,(H,20,21,23)/t12-,13-,15-,16-,19-/m1/s1 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-[(1R)-2,3-dihydro-1H-inden-1-yl]adenosine |
|
![T9R T9R](https://data.pdbj.org/pdbjplus/data/cc/svg/T9R.svg) | T9R | Name: | N-[(4-hydroxyphenyl)methyl]adenosine | Formula: | C17 H19 N5 O5 | SMILES: | Oc1ccc(cc1)CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O | InChi: | InChI=1S/C17H19N5O5/c23-6-11-13(25)14(26)17(27-11)22-8-21-12-15(19-7-20-16(12)22)18-5-9-1-3-10(24)4-2-9/h1-4,7-8,11,13-14,17,23-26H,5-6H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-[(4-hydroxyphenyl)methyl]adenosine |
|
![TAI TAI](https://data.pdbj.org/pdbjplus/data/cc/svg/TAI.svg) | TAI | Name: | N-[3-(4-aminophenyl)propyl]adenosine | Formula: | C19 H24 N6 O4 | SMILES: | Nc1ccc(cc1)CCCNc1ncnc2c1ncn2C1OC(CO)C(O)C1O | InChi: | InChI=1S/C19H24N6O4/c20-12-5-3-11(4-6-12)2-1-7-21-17-14-18(23-9-22-17)25(10-24-14)19-16(28)15(27)13(8-26)29-19/h3-6,9-10,13,15-16,19,26-28H,1-2,7-8,20H2,(H,21,22,23)/t13-,15-,16-,19-/m1/s1 | Definition date: | 2022-07-20 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-[3-(4-aminophenyl)propyl]adenosine |
|
![UY9 UY9](https://data.pdbj.org/pdbjplus/data/cc/svg/UY9.svg) | UY9 | Name: | 6-ethyl-4-[(5P)-7-[(1H-imidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-1-oxo-3,4-dihydroisoquinolin-2(1H)-yl]-N-methylquinoline-8-carboxamide | Formula: | C31 H28 F3 N7 O2 | SMILES: | FC(F)(F)c1nn(C)cc1c1cc(Cn2ccnc2)cc2C(=O)N(CCc12)c1ccnc2c1cc(CC)cc2C(=O)NC | InChi: | InChI=1S/C31H28F3N7O2/c1-4-18-11-23-26(5-7-37-27(23)24(12-18)29(42)35-2)41-9-6-20-21(25-16-39(3)38-28(25)31(32,33)34)13-19(14-22(20)30(41)43)15-40-10-8-36-17-40/h5,7-8,10-14,16-17H,4,6,9,15H2,1-3H3,(H,35,42) | Definition date: | 2022-08-29 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 6-ethyl-4-[(5P)-7-[(1H-imidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-1-oxo-3,4-dihydroisoquinolin-2(1H)-yl]-N-methylquinoline-8-carboxamide |
|
![X8N X8N](https://data.pdbj.org/pdbjplus/data/cc/svg/X8N.svg) | X8N | Name: | (2S)-2-({(2S)-3-(3'-chloro[1,1'-biphenyl]-4-yl)-1-oxo-1-[(1H-tetrazol-5-yl)amino]propan-2-yl}oxy)propanoic acid | Formula: | C19 H18 Cl N5 O4 | SMILES: | O=C(Nc1nnn[NH]1)C(Cc1ccc(cc1)c1cccc(Cl)c1)OC(C)C(=O)O | InChi: | InChI=1S/C19H18ClN5O4/c1-11(18(27)28)29-16(17(26)21-19-22-24-25-23-19)9-12-5-7-13(8-6-12)14-3-2-4-15(20)10-14/h2-8,10-11,16H,9H2,1H3,(H,27,28)(H2,21,22,23,24,25,26)/t11-,16-/m0/s1 | Definition date: | 2022-11-07 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (2S)-2-({(2S)-3-(3'-chloro[1,1'-biphenyl]-4-yl)-1-oxo-1-[(1H-tetrazol-5-yl)amino]propan-2-yl}oxy)propanoic acid |
|
![XPZ XPZ](https://data.pdbj.org/pdbjplus/data/cc/svg/XPZ.svg) | XPZ | Name: | (2~{S})-2-(hexadecanoylamino)-3-phenyl-propanoic acid | Formula: | C25 H41 N O3 | SMILES: | CCCCCCCCCCCCCCCC(=O)N[CH](Cc1ccccc1)C(O)=O | InChi: | InChI=1S/C25H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-24(27)26-23(25(28)29)21-22-18-15-14-16-19-22/h14-16,18-19,23H,2-13,17,20-21H2,1H3,(H,26,27)(H,28,29)/t23-/m0/s1 | Definition date: | 2022-01-06 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (2~{S})-2-(hexadecanoylamino)-3-phenyl-propanoic acid |
|
![KG6 KG6](https://data.pdbj.org/pdbjplus/data/cc/svg/KG6.svg) | KG6 | Name: | 3-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azanylethyl)amino]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylamino]-3-oxidanylidene-propanoic acid | Formula: | C28 H35 N13 O9 | SMILES: | NCCN(CC#Cc1nc2c(N)ncnc2n1[CH]3O[CH](CNC(=O)CC(O)=O)[CH](O)[CH]3O)C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C28H35N13O9/c29-3-5-39(8-13-20(46)21(47)27(50-13)40-11-37-17-23(30)33-9-35-25(17)40)4-1-2-14-38-18-24(31)34-10-36-26(18)41(14)28-22(48)19(45)12(49-28)7-32-15(42)6-16(43)44/h9-13,19-22,27-28,45-48H,3-8,29H2,(H,32,42)(H,43,44)(H2,30,33,35)(H2,31,34,36)/t12-,13-,19-,20-,21-,22-,27-,28-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 3-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azanylethyl)amino]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylamino]-3-oxidanylidene-propanoic acid |
|
![KGI KGI](https://data.pdbj.org/pdbjplus/data/cc/svg/KGI.svg) | KGI | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethanoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid | Formula: | C27 H33 N13 O9 | SMILES: | NCC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)CC(O)=O | InChi: | InChI=1S/C27H33N13O9/c28-4-14(41)31-5-11-18(44)21(47)27(48-11)40-13(37-17-23(30)33-9-35-25(17)40)2-1-3-38(7-15(42)43)6-12-19(45)20(46)26(49-12)39-10-36-16-22(29)32-8-34-24(16)39/h8-12,18-21,26-27,44-47H,3-7,28H2,(H,31,41)(H,42,43)(H2,29,32,34)(H2,30,33,35)/t11-,12-,18-,19-,20-,21-,26-,27-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethanoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid |
|
![KGX KGX](https://data.pdbj.org/pdbjplus/data/cc/svg/KGX.svg) | KGX | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethylcarbamoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid | Formula: | C28 H36 N14 O9 | SMILES: | NCCNC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)CC(O)=O | InChi: | InChI=1S/C28H36N14O9/c29-3-4-32-28(49)33-6-12-18(45)21(48)27(50-12)42-14(39-17-23(31)35-10-37-25(17)42)2-1-5-40(8-15(43)44)7-13-19(46)20(47)26(51-13)41-11-38-16-22(30)34-9-36-24(16)41/h9-13,18-21,26-27,45-48H,3-8,29H2,(H,43,44)(H2,30,34,36)(H2,31,35,37)(H2,32,33,49)/t12-,13-,18-,19-,20-,21-,26-,27-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethylcarbamoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid |
|
![KH9 KH9](https://data.pdbj.org/pdbjplus/data/cc/svg/KH9.svg) | KH9 | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(3-azanylpropylcarbamoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid | Formula: | C29 H38 N14 O9 | SMILES: | NCCCNC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)CC(O)=O | InChi: | InChI=1S/C29H38N14O9/c30-4-2-5-33-29(50)34-7-13-19(46)22(49)28(51-13)43-15(40-18-24(32)36-11-38-26(18)43)3-1-6-41(9-16(44)45)8-14-20(47)21(48)27(52-14)42-12-39-17-23(31)35-10-37-25(17)42/h10-14,19-22,27-28,46-49H,2,4-9,30H2,(H,44,45)(H2,31,35,37)(H2,32,36,38)(H2,33,34,50)/t13-,14-,19-,20-,21-,22-,27-,28-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(3-azanylpropylcarbamoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid |
|
![S9C S9C](https://data.pdbj.org/pdbjplus/data/cc/svg/S9C.svg) | S9C | Name: | 7-(6-fluoranylpyridin-3-yl)-5~{H}-pyrido[4,3-b]indole | Formula: | C16 H10 F N3 | SMILES: | Fc1ccc(cn1)c2ccc3c([nH]c4ccncc34)c2 | InChi: | InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H | Definition date: | 2022-12-14 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 7-(6-fluoranylpyridin-3-yl)-5~{H}-pyrido[4,3-b]indole |
|
![Q8R Q8R](https://data.pdbj.org/pdbjplus/data/cc/svg/Q8R.svg) | Q8R | Name: | N-(2-phenylethyl)adenosine | Formula: | C18 H21 N5 O4 | SMILES: | OCC1OC(n2cnc3c(NCCc4ccccc4)ncnc32)C(O)C1O | InChi: | InChI=1S/C18H21N5O4/c24-8-12-14(25)15(26)18(27-12)23-10-22-13-16(20-9-21-17(13)23)19-7-6-11-4-2-1-3-5-11/h1-5,9-10,12,14-15,18,24-26H,6-8H2,(H,19,20,21)/t12-,14-,15-,18-/m1/s1 | Definition date: | 2022-06-01 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-(2-phenylethyl)adenosine |
|
![KHL KHL](https://data.pdbj.org/pdbjplus/data/cc/svg/KHL.svg) | KHL | Name: | (1~{R},24~{R},25~{S},26~{R})-14-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-7-azanyl-25,26-bis(oxidanyl)-27-oxa-2,4,6,9,14,17,20,22-octazatetracyclo[22.2.1.0^{2,10}.0^{3,8}]heptacosa-3(8),4,6,9-tetraen-11-yne-16,21-dione | Formula: | C28 H34 N14 O8 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN4CC#Cc5nc6c(N)ncnc6n5[CH]7O[CH](CNC(=O)NCCNC(=O)C4)[CH](O)[CH]7O)[CH](O)[CH]3O | InChi: | InChI=1S/C28H34N14O8/c29-22-16-24(36-9-34-22)41(11-38-16)26-20(46)19(45)13(50-26)7-40-5-1-2-14-39-17-23(30)35-10-37-25(17)42(14)27-21(47)18(44)12(49-27)6-33-28(48)32-4-3-31-15(43)8-40/h9-13,18-21,26-27,44-47H,3-8H2,(H,31,43)(H2,29,34,36)(H2,30,35,37)(H2,32,33,48)/t12-,13-,18-,19-,20-,21-,26-,27-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (1~{R},24~{R},25~{S},26~{R})-14-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-7-azanyl-25,26-bis(oxidanyl)-27-oxa-2,4,6,9,14,17,20,22-octazatetracyclo[22.2.1.0^{2,10}.0^{3,8}]heptacosa-3(8),4,6,9-tetraen-11-yne-16,21-dione |
|
![Q8Y Q8Y](https://data.pdbj.org/pdbjplus/data/cc/svg/Q8Y.svg) | Q8Y | Name: | N-(3-phenylpropyl)adenosine | Formula: | C19 H23 N5 O4 | SMILES: | OCC1OC(n2cnc3c(NCCCc4ccccc4)ncnc32)C(O)C1O | InChi: | InChI=1S/C19H23N5O4/c25-9-13-15(26)16(27)19(28-13)24-11-23-14-17(21-10-22-18(14)24)20-8-4-7-12-5-2-1-3-6-12/h1-3,5-6,10-11,13,15-16,19,25-27H,4,7-9H2,(H,20,21,22)/t13-,15-,16-,19-/m1/s1 | Definition date: | 2022-06-01 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-(3-phenylpropyl)adenosine |
|
![Q8C Q8C](https://data.pdbj.org/pdbjplus/data/cc/svg/Q8C.svg) | Q8C | Name: | N-benzyladenosine | Formula: | C17 H19 N5 O4 | SMILES: | OCC1OC(n2cnc3c(NCc4ccccc4)ncnc32)C(O)C1O | InChi: | InChI=1S/C17H19N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-25H,6-7H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1 | Definition date: | 2022-06-01 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-benzyladenosine |
|
![KHX KHX](https://data.pdbj.org/pdbjplus/data/cc/svg/KHX.svg) | KHX | Name: | (1~{R},23~{R},24~{S},25~{R})-14-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-7-azanyl-24,25-bis(oxidanyl)-26-oxa-2,4,6,9,14,17,21-heptazatetracyclo[21.2.1.0^{2,10}.0^{3,8}]hexacosa-3(8),4,6,9-tetraen-11-yne-18,20-dione | Formula: | C28 H33 N13 O8 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN4CCNC(=O)CC(=O)NC[CH]5O[CH]([CH](O)[CH]5O)n6c(nc7c(N)ncnc67)C#CC4)[CH](O)[CH]3O | InChi: | InChI=1S/C28H33N13O8/c29-23-17-25(35-9-33-23)40(11-37-17)27-21(46)20(45)13(49-27)8-39-4-1-2-14-38-18-24(30)34-10-36-26(18)41(14)28-22(47)19(44)12(48-28)7-32-16(43)6-15(42)31-3-5-39/h9-13,19-22,27-28,44-47H,3-8H2,(H,31,42)(H,32,43)(H2,29,33,35)(H2,30,34,36)/t12-,13-,19-,20-,21-,22-,27-,28-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (1~{R},23~{R},24~{S},25~{R})-14-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-7-azanyl-24,25-bis(oxidanyl)-26-oxa-2,4,6,9,14,17,21-heptazatetracyclo[21.2.1.0^{2,10}.0^{3,8}]hexacosa-3(8),4,6,9-tetraen-11-yne-18,20-dione |
|
![Q8L Q8L](https://data.pdbj.org/pdbjplus/data/cc/svg/Q8L.svg) | Q8L | Name: | Piclidenoson | Formula: | C18 H19 I N6 O4 | SMILES: | Ic1cccc(c1)CNc1ncnc2c1ncn2C1OC(C(O)C1O)C(=O)NC | InChi: | InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1 | Definition date: | 2022-06-01 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | (2S,3S,4R,5R)-3,4-dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboxamide (non-preferred name) |
|
![KIC KIC](https://data.pdbj.org/pdbjplus/data/cc/svg/KIC.svg) | KIC | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(3-azanylpropanoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid | Formula: | C28 H35 N13 O9 | SMILES: | NCCC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)CC(O)=O | InChi: | InChI=1S/C28H35N13O9/c29-4-3-15(42)32-6-12-19(45)22(48)28(49-12)41-14(38-18-24(31)34-10-36-26(18)41)2-1-5-39(8-16(43)44)7-13-20(46)21(47)27(50-13)40-11-37-17-23(30)33-9-35-25(17)40/h9-13,19-22,27-28,45-48H,3-8,29H2,(H,32,42)(H,43,44)(H2,30,33,35)(H2,31,34,36)/t12-,13-,19-,20-,21-,22-,27-,28-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(3-azanylpropanoylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid |
|
![KIG KIG](https://data.pdbj.org/pdbjplus/data/cc/svg/KIG.svg) | KIG | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethylsulfonylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid | Formula: | C27 H35 N13 O10 S | SMILES: | NCC[S](=O)(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)CC(O)=O | InChi: | InChI=1S/C27H35N13O10S/c28-3-5-51(47,48)36-6-12-18(43)21(46)27(49-12)40-14(37-17-23(30)32-10-34-25(17)40)2-1-4-38(8-15(41)42)7-13-19(44)20(45)26(50-13)39-11-35-16-22(29)31-9-33-24(16)39/h9-13,18-21,26-27,36,43-46H,3-8,28H2,(H,41,42)(H2,29,31,33)(H2,30,32,34)/t12-,13-,18-,19-,20-,21-,26-,27-/m1/s1 | Definition date: | 2022-05-25 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-[(2-azanylethylsulfonylamino)methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]ethanoic acid |
|
![Q9W Q9W](https://data.pdbj.org/pdbjplus/data/cc/svg/Q9W.svg) | Q9W | Name: | N-(4-phenylbutyl)adenosine | Formula: | C20 H25 N5 O4 | SMILES: | OCC1OC(n2cnc3c(NCCCCc4ccccc4)ncnc32)C(O)C1O | InChi: | InChI=1S/C20H25N5O4/c26-10-14-16(27)17(28)20(29-14)25-12-24-15-18(22-11-23-19(15)25)21-9-5-4-8-13-6-2-1-3-7-13/h1-3,6-7,11-12,14,16-17,20,26-28H,4-5,8-10H2,(H,21,22,23)/t14-,16-,17-,20-/m1/s1 | Definition date: | 2022-06-03 | Last modified: | 2023-01-06 | Release date: | 2023-01-11 | Identifier: | N-(4-phenylbutyl)adenosine |
|